Dec 8, 2021RecruitingNCT05113342: Phase 1/2: Descartes-25 in Relapsed/Refractory Multiple MyelomaNCT05113342: Phase 1/2: Descartes-25 in Relapsed/Refractory Multiple Myeloma Descartes-25 in Relapsed/Refractory Multiple Myeloma This is...